Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma. Tsilimigras DI, Woldesenbet S, Chatzipanagiotou OP, Iyer S, et al. Surgery 2024 Sep 19:S0039-6060(24)00641-X. doi: 10.1016/j.surg.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Tsilimigras DI, Woldesenbet S, Chatzipanagiotou OP, Iyer S, et al. Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma. Surgery 2024 Sep 19:S0039-6060(24)00641-X. doi: 10.1016/j.surg.2024.
PMID: 39304446